SK Tahir, X Yang, MG Anderson, SE Morgan-Lappe… - Cancer research, 2007 - AACR
ABT-737 is a novel and potent Bcl-2 antagonist with single-agent activity against small-cell
lung cancer (SCLC) cell lines. Here, we evaluated the contribution of Bcl-2 family members …